Mark G. Bures
11Patents
3h-index
14Co-inventors
57Inventor score
Filing activity: Nov 5, 1993 → Jul 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10377748B2 | Hepatitis B core protein modulators | Chemistry; Metallurgy | 7 | Active |
| US10392379B2 | Hepatitis B core protein modulators | Chemistry; Metallurgy | 6 | Active |
| US5516647A | Compounds useful as alkaline phosphatase inhibitors and therapeutic agents | Emerging Cross-Sectional Technologies | 3 | Expired |
| US11560370B1 | 5-membered heteroaryl carboxamide compounds for treatment of HBV | Chemistry; Metallurgy | 0 | Active |
| US10968211B2 | Hepatitis B core protein modulators | Chemistry; Metallurgy | 0 | Active |
| US11976075B2 | Inhibitors of the MYST family of lysine acetyl transferases | Chemistry; Metallurgy | 0 | Active |
| US10987360B2 | Hepatitis B core protein modulators | Chemistry; Metallurgy | 0 | Active |
| US11078170B2 | Cyclic sulfamide compounds and methods of using same | Chemistry; Metallurgy | 0 | Active |
| US12030869B2 | 5-membered heteroaryl carboxamide compounds for treatment of HBV | Chemistry; Metallurgy | 0 | Active |
| US12187732B2 | Inhibitors of the myst family of lysine acetyl transferases | Chemistry; Metallurgy | 0 | Active |
| US11814376B2 | Hepatitis b core protein modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.